Vosbuta (2.5ml Each) 0.31mg Respules
Marketer
Nourier Lab
Salt Composition
Levosalbutamol (0.31mg)
Overview Vosbuta (2.5ml Each) 0.31mg Respules
Respi-Aid (2.5ml Each) 0.31mg ampoules are fast-acting bronchodilators, providing rapid relief from asthma and chronic obstructive pulmonary disease (COPD) symptoms like wheezing, coughing, and breathlessness. Respi-Aid offers immediate relief from respiratory distress; however, it's typically used in conjunction with a preventative inhaler to manage ongoing symptoms. Its effects endure for several hours, and while usable anytime, it should only be employed when symptoms (coughing, wheezing, chest tightness, shortness of breath) arise or before potentially strenuous activities. During an asthma attack, administer the prescribed number of doses. Proper inhaler technique is crucial for efficacy. Discontinue use only under medical supervision, as cessation may exacerbate breathing difficulties. Potential side effects, including bronchitis, dizziness, pain, sore throat, pharyngitis, nasal congestion, vomiting, tremors, palpitations, chest pain, and accidental injury, are generally mild and transient. Severe side effects (intense headache, severe dizziness, chest pain) necessitate immediate medical attention. Before using Respi-Aid, inform your doctor of any pre-existing conditions, such as hypertension, hyperthyroidism, cardiac history, diabetes, or hypokalemia. Disclose pregnancy or breastfeeding. Due to potential dizziness or shakiness, avoid operating machinery or vehicles until symptom resolution. Smoking should be avoided as it worsens lung health and disease progression.
Uses of Vosbuta (2.5ml Each) 0.31mg Respules
Managing Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Major Benefits of Vosbuta (2.5ml Each) 0.31mg Respules:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Always consult the product label for instructions prior to use. Open the respule/transpule by twisting off the cap and completely transfer the contents into the nebulizer for immediate inhalation.
Common Side effects of Vosbuta (2.5ml Each) 0.31mg Respules:
- Accidental injury
- Bronchitis (inflammation of the airways)
- Dizziness
- Pain
- Pharyngitis
- Nasal congestion (stuffy nose)
- Vomiting
- Chest pain
- Palpitations
- Sore throat
- Tremors
How to use Vosbuta (2.5ml Each) 0.31mg Respules:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Consult the product label for detailed instructions prior to use. Remove the respule/transpule cap by twisting and completely empty the contents into the nebulizer for immediate inhalation.
How Vosbuta (2.5ml Each) 0.31mg Respules works:
Each 2.5ml Vosbuta respule delivers 0.31mg of bronchodilating medication. It achieves this by relaxing airway muscles, thus widening the airways and facilitating easier respiration.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Vosbuta (2.5ml Respules, 0.31mg each) and alcohol may result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Vosbuta Respules (2.5ml, 0.31mg each) during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Vosbuta Respules (2.5ml, 0.31mg each) are considered safe for use while breastfeeding. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingNone
No drug interaction identified.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Vosbuta (2.5ml Each) 0.31mg Respules :
Omit any missed dose of Vosbuta (2.5ml Respules, 0.31mg each); resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vosbuta (2.5ml Each) 0.31mg Respules
| Label | Value |
|---|---|
| Chemical Category | Benzyl Alcohol Derivatives |
| Developing Habits | No. |
| Treatment Category | Breathing |
| Active Class | Short-acting beta-2 agonists |


